Uche Kennedy: Hemophilia Care Needs Systems Reform, Not Short-Term Fixes
Uche Kennedy, Digital Communications Specialist at Nigeria Health Watch, shared a post on LinkedIn:
”Hemophilia is often described as ‘rare.’
But after spending two days in conversations around inherited blood disorders, I keep thinking that what’s actually rare is a health system that truly supports people living with it.
At the Inherited Blood Disorders Leadership Forum in Abuja, the discussions went far beyond medicine. Again and again, haemophilia showed up as a mirror reflecting deeper issues: gaps in financing, weak data systems, fragmented care, and the heavy burden placed on families to navigate it all on their own.
One key takeaway for me: Lifelong conditions cannot depend on short-term solutions. They need predictable financing, integrated care at the primary healthcare level, insurance that actually works, and data that guides decisions rather than reacts to crises.
What stood out wasn’t just the expertise in the room, but the clarity. When haemophilia is treated as an afterthought, people fall through the cracks. When recognised as a systems issue, the conversation shifts to policy coherence, coordination, sustainability, and accountability.
Kudos to the NSHBT Official, National Blood Service Agency, Nigeria, Novo Nordisk Foundation, and the Novo Nordisk Haemophilia & Haemoglobinopathies Foundation, for convening this timely dialogue.
Now the real question is:
How do we move from strong conversations to clear timelines, measurable commitments, and care that works consistently for people living with haemophilia?”
Keep up with Hemostasis Today.
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval
-
Oct 19, 2026, 10:28Brig Tathagata Chatterjee: Acute Leukemias in AYAs at the Japanese Society of Hematology Conference
-
Oct 19, 2026, 10:27Heather M. Johnson: Join the Discussion on Optimizing the CTEPH Diagnostic Pathway
-
Oct 19, 2026, 10:18Flora Peyvandi: Unravelling the Complexity of VWF Through Genetics
-
Oct 19, 2026, 09:55High DOAC Adherence in Patients With Ischemic Stroke and AF – International Journal of Stroke